Related Research Articles
An epinephrine autoinjector is a medical device for injecting a measured dose or doses of epinephrine (adrenaline) by means of autoinjector technology. It is most often used for the treatment of anaphylaxis. The first epinephrine autoinjector was brought to market in 1983.
Cardinal Health, Inc. is an American multinational health care services company, and the 14th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical product, including gloves, surgical apparel, and fluid management products. In addition, it operates one of the largest networks of radiopharmacies in the U.S. Cardinal Health provides medical products to over 75 percent of hospitals in the United States.
Barr Pharmaceuticals was a global specialty and generic drug manufacturer with operations in 30 countries.
Mylan N.V. was a global generic and specialty pharmaceuticals company. In November 2020, Mylan merged with Upjohn, Pfizer's off-patent medicine division, to form Viatris. Previously, the company was domiciled in the Netherlands, with principal executive offices in Hatfield, Hertfordshire, UK and a "Global Center" in Canonsburg, Pennsylvania, US.
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients (API's) and, to a lesser extent, contract manufacturing services and an out-licensing platform.
Actavis Generics is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products. Actavis has a commercial presence across approximately 100 countries. The company has global headquarters in Dublin, Ireland and administrative headquarters in Parsippany-Troy Hills, New Jersey, United States.
Winston & Strawn LLP is an international law firm headquartered in Chicago. It has more than 900 attorneys spread across ten offices in the United States and six offices in Europe, Asia and South America. Founded in 1853, it is one of the largest and oldest law firms in Chicago.
Cephalon, Inc. was an American biopharmaceutical company co-founded in 1987 by pharmacologist Frank Baldino, Jr., neuroscientist Michael Lewis, and organic chemist James C. Kauer—all three former scientists with the DuPont Company. Baldino served as Cephalon's chairman and chief executive officer, until his death in December 2010. The company's name comes from the adjective "cephalic" meaning "related to the head or brain", as it was established primarily to pursue treatments for neurodegenerative diseases.
Isaac Kaye is a businessman with interests in healthcare and politics in the United Kingdom. Originally from South Africa, he obtained Irish citizenship upon his arrival in the UK in 1985.
Pankaj Ramanbhai Patel is an Indian billionaire businessman, and the chairman of Zydus Lifesciences, the fifth largest pharmaceutical company in India.
Terry McGuire is a co-founder and general partner of Polaris Partners based in the Boston office. McGuire focuses on life sciences investments.
Phillip Frost is an American entrepreneur.
Arie S. Belldegrun, FACS, is an Israeli-American urologic oncologist, billionaire businessman and investor.
George S. Barrett is an American business executive in the health care industry. He served as chairman and chief executive officer of Cardinal Health, Inc. from 2009 to 2017. He joined the board of the Columbus Foundation in December 2017.
Greenhill & Co., Inc. is an American investment banking advisory firm founded in 1996 by Robert F. Greenhill. The firm provides advice on significant mergers, acquisitions, restructurings, financings, and capital raisings to leading corporations, partnerships, institutions and governments across a number of industries. Since its inception, Greenhill has advised on transactions valued at close to $3 trillion.
Henri A. Termeer was a Dutch biotechnology executive and entrepreneur who is considered a pioneer in corporate strategy in the biotechnology industry for his tenure as CEO at Genzyme. Termeer created a business model adopted by many others in the biotech industry by garnering steep prices— mainly from insurers and government payers— for therapies for rare genetic disorders known as orphan diseases that mainly affect children. Genzyme uses biological processes to manufacture drugs that are not easily copied by generic-drug makers. The drugs are also protected by orphan drug acts in various countries which provides extensive protection from competition and ensures coverage by publicly funded insurers. As CEO of Genzyme from 1981 to 2011, he developed corporate strategies for growth including optimizing institutional embeddedness nurturing vast networks of influential groups and clusters: doctors, private equity, patient-groups, insurance, healthcare umbrella organizations, state and local government, and alumni. Termeer was "connected to 311 board members in 17 different organizations across 20 different industries" He has the legacy of being the "longest-serving CEO in the biotechnology industry.
Allergan plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology. The company is the maker of Botox.
Alvogen is an Icelandic pharmaceutical company founded in 2009. In 2014, a controlling stake in the company was acquired by CVC Capital Partners and Temasek Holdings. Alvogen has about 350 different medical and non-medical products, and both produces its own products and markets the products of brand name pharmaceutical companies.
Jeffrey Leiden is an American physician, scientist and businessman who is the executive chairman of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts. He was initially appointed to the board of directors of the company in 2009 and was CEO and president from February 2012 to March 2020.
Harvey Mark Krueger was an American investment banker, former CEO and President of Kuhn, Loeb & Co. known for being the first banker to bring Israel to the international capital markets and helped broker the merger between Kuhn, Loeb & Co. and Lehman Brothers in 1977. He also served as the vice chairman of Lehman Brothers and Barclays.
References
- 1 2 "Bloomberg: Bruce L. Downey J.D." Bloomberg. Retrieved 20 August 2016.
- ↑ "Bruce Downey, Generic-Drug Lord". Bloomberg Businessweek . Business Week Online. October 1, 2001. Archived from the original on November 15, 2001. Retrieved 7 September 2010.
- ↑ "Teva Coughs Up $7.46B for Barr Reinforcing Its Number One Spot in the Generics Market". Genetic, Engineering & Biotechnology News. July 18, 2008. Retrieved 7 September 2010.
- ↑ "Bruce Downey named Ernst & Young Entrepreneur Of The Year 2009 Winner in the Health Sciences category - Ernst & Young - United States". Ernst & Young . Palm Springs: Ernst & Young. 15 November 2009. Archived from the original on 23 November 2009. Retrieved 7 September 2010.
 | This article about a United States businessperson is a stub. You can help Wikipedia by expanding it. |